Balderton Capital: Investments against COVID-19 UK Investors
Entity: Balderton Capital
Description: Balderton Capital is Europe’s leading venture firm focused exclusively on technology companies founded in Europe. They primarily invest at Series A and are the most active Series A investor in Europe. In parallel, run a Liquidity fund for later stage secondary investments in fast-growth, European founded technology startups. They have been investing in Europe for twenty years from their headquarters in London, and have raised eight funds totalling over $3Bn. They have over 90 companies in its active Portfolio, founded in 15 countries across Europe, today employing over 18,000 employees in more than 50 countries worldwide.
+ Investing in:
. Healx
. Zego
Description: Balderton Capital is Europe’s leading venture firm focused exclusively on technology companies founded in Europe. They primarily invest at Series A and are the most active Series A investor in Europe. In parallel, run a Liquidity fund for later stage secondary investments in fast-growth, European founded technology startups. They have been investing in Europe for twenty years from their headquarters in London, and have raised eight funds totalling over $3Bn. They have over 90 companies in its active Portfolio, founded in 15 countries across Europe, today employing over 18,000 employees in more than 50 countries worldwide.
+ Investing in:
. Healx
. Zego
Technology:
COVID UK Funding&Support
Industry:
COVID UK Non-governmental Bodies
Headquarters:
United Kingdom
Founded Date:
N/A
Employees Number:
N/A
Funding Status:
N/A
Investor Type:
N/A
Investment Stage:
N/A
Number Of Exits:
N/A
Register and Claim Ownership